132 related articles for article (PubMed ID: 9492043)
1. p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1.
Ohlsson C; Kley N; Werner H; LeRoith D
Endocrinology; 1998 Mar; 139(3):1101-7. PubMed ID: 9492043
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53.
Rubinstein M; Idelman G; Plymate SR; Narla G; Friedman SL; Werner H
Endocrinology; 2004 Aug; 145(8):3769-77. PubMed ID: 15131018
[TBL] [Abstract][Full Text] [Related]
3. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.
Webster NJ; Resnik JL; Reichart DB; Strauss B; Haas M; Seely BL
Cancer Res; 1996 Jun; 56(12):2781-8. PubMed ID: 8665514
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.
Glait C; Tencer L; Ravid D; Sarfstein R; Liscovitch M; Werner H
Exp Cell Res; 2006 Nov; 312(19):3899-908. PubMed ID: 17014845
[TBL] [Abstract][Full Text] [Related]
6. p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy.
Attias-Geva Z; Bentov I; Kidron D; Amichay K; Sarfstein R; Fishman A; Bruchim I; Werner H
Eur J Cancer; 2012 Jul; 48(10):1570-80. PubMed ID: 22033326
[TBL] [Abstract][Full Text] [Related]
7. Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1.
Shahrabani-Gargir L; Pandita TK; Werner H
Endocrinology; 2004 Dec; 145(12):5679-87. PubMed ID: 15345673
[TBL] [Abstract][Full Text] [Related]
8. HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene.
Aiello A; Pandini G; Sarfstein R; Werner H; Manfioletti G; Vigneri R; Belfiore A
Eur J Cancer; 2010 Jul; 46(10):1919-26. PubMed ID: 20335021
[TBL] [Abstract][Full Text] [Related]
9. Folic acid and its metabolites modulate IGF-I receptor gene expression in colon cancer cells in a p53-dependent manner.
Attias Z; Werner H; Vaisman N
Endocr Relat Cancer; 2006 Jun; 13(2):571-81. PubMed ID: 16728583
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
[TBL] [Abstract][Full Text] [Related]
11. WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation.
Idelman G; Glaser T; Roberts CT; Werner H
J Biol Chem; 2003 Jan; 278(5):3474-82. PubMed ID: 12444079
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact.
Girnita L; Girnita A; Brodin B; Xie Y; Nilsson G; Dricu A; Lundeberg J; Wejde J; Bartolazzi A; Wiman KG; Larsson O
Cancer Res; 2000 Sep; 60(18):5278-83. PubMed ID: 11016658
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.
Damon SE; Plymate SR; Carroll JM; Sprenger CC; Dechsukhum C; Ware JL; Roberts CT
Endocrinology; 2001 Jan; 142(1):21-7. PubMed ID: 11145562
[TBL] [Abstract][Full Text] [Related]
14. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
Mur C; Arribas M; Benito M; Valverde AM
Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1.
Maor SB; Abramovitch S; Erdos MR; Brody LC; Werner H
Mol Genet Metab; 2000 Feb; 69(2):130-6. PubMed ID: 10720440
[TBL] [Abstract][Full Text] [Related]
16. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor I increases rat peptide YY promoter activity through Sp1 binding sites.
Wang G; Leiter AB; Englander EW; Greeley GH
Endocrinology; 2004 Feb; 145(2):659-66. PubMed ID: 14592960
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
[TBL] [Abstract][Full Text] [Related]
19. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
[TBL] [Abstract][Full Text] [Related]
20. Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I.
Liefvendahl E; Arnqvist HJ
Horm Metab Res; 2008 Jun; 40(6):369-74. PubMed ID: 18393172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
